ArticleCell death & disease2020

CB13, a novel PPARγ ligand, overcomes radio-resistance via ROS generation and ER stress in human non-small cell lung cancer.

Tae Woo Kim et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.